Atlas Trials

PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer

Clinical trial NCT03971214 · UNKNOWN

Trial details

NCT number
NCT03971214
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Extensive-stage Small Cell Lung CancerRadiotherapyImmunotherapy
Start date
2019-06-01
Primary completion
2020-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.